Comparable findings were replicated in the TCGA database (Fig. 3E–H), reinforcing the notion that RBM47 plays a pivotal role in modulating immunity, inflammation, immune-mediated disorders, as well as the intricate glioma microenvironment. The gene discussed is RBM47; the disease is central nervous system cancer.